Sale of unaffected batches of Medicube capsule cream can resume: HSA

Sudan IV was not detected in samples submitted by APR SG and Rirora International, and the companies may resume sales of their unaffected batches, HSA said.

The affected batches sold by Venus Beauty are batch numbers 2E122I.2E117I and 2E191G.2E193G.

Sudan Red dyes, including Sudan IV, are not permitted for use in cosmetic products. 

The group of dyes is normally used to colour plastics and other synthetic materials, and has been found to have carcinogenic effects, according to the European Commission. The dyes also pose a potential risk of genotoxicity, meaning they may damage genetic material.

“Although the quantities detected in the affected batches are in minute amounts and are unlikely to pose any serious health risks from previous use, consumers should not continue using the affected products and should contact the seller if they have concerns related to refunds,” HSA said.

“HSA has not received any local reports of adverse events associated with the product to date.”